MeiraGTx Holdings (MGTX) Capital Expenditures Growth (1y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 227.76% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.57% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 143.40% |
| 10 | MeiraGTx Holdings | 856.58 Mn | 790.65 Mn | 74.89 Mn | -77.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -77.67% |
| Sep 30, 2025 | -16.44% |
| Jun 30, 2025 | -7.15% |
| Mar 31, 2025 | 1.91% |
| Dec 31, 2024 | -59.80% |
| Sep 30, 2024 | -79.52% |
| Jun 30, 2024 | -73.29% |
| Mar 31, 2024 | -80.50% |
| Dec 31, 2023 | -64.32% |
| Sep 30, 2023 | -64.40% |
| Jun 30, 2023 | -64.46% |
| Mar 31, 2023 | -30.94% |
| Dec 31, 2022 | -65.15% |
| Sep 30, 2022 | -15.91% |
| Jun 30, 2022 | 151.12% |
| Mar 31, 2022 | 176.77% |
| Dec 31, 2021 | 204.04% |
| Sep 30, 2021 | 99.85% |
| Jun 30, 2021 | 91.19% |
| Mar 31, 2021 | 11.55% |
| Dec 31, 2020 | 68.75% |
| Sep 30, 2020 | 194.36% |
| Jun 30, 2020 | 167.09% |
| Mar 31, 2020 | 261.90% |
| Dec 31, 2019 | -46.55% |
| Sep 30, 2019 | 91.90% |
| Jun 30, 2019 | 914.99% |
| Mar 31, 2019 | -7.87% |
| Dec 31, 2018 | 313.96% |
| Sep 30, 2018 | -70.41% |